Biologicals

Thiomersal

Thiomersal WHO Consultation on the impact of thiomersal on quality, safety & efficacy of vaccines: regulatory perspectives

Geneva, 15-16 April 2002

UPCOMING EVENTS


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971